Skip to content

Chemed CHE Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

GHC
Graham HoldingsGHC
$286K

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's stock issuance proceeds?
Chemed (CHE) reported stock issuance proceeds of $1.31M in Q1 2026.
How has Chemed's stock issuance proceeds changed year-over-year?
Chemed's stock issuance proceeds decreased by 94.2% year-over-year, from $22.67M to $1.31M.
What is the long-term trend for Chemed's stock issuance proceeds?
Over 3 years (2021 to 2024), Chemed's stock issuance proceeds has grown at a 16.4% compound annual growth rate (CAGR), from $35.85M to $56.52M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.